argenx SE
XBRU:ARGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
argenx SE
XBRU:ARGX
|
NL |
|
Angkor Resources Corp
XTSX:ANK
|
CA |
|
Delivery Hero SE
XETRA:DHER
|
DE |
|
A
|
Atoss Software AG
XMUN:AOF
|
DE |
|
P
|
Puma SE
DUS:PUM
|
DE |
|
M
|
MGIC Investment Corp
F:MGC
|
US |
|
Indoritel Makmur Internasional Tbk PT
IDX:DNET
|
ID |
|
Derwent London PLC
LSE:DLN
|
UK |
|
Saul Centers Inc
NYSE:BFS
|
US |
|
I
|
Impianti SpA
MIL:MPT
|
IT |
|
Perrigo Company PLC
NYSE:PRGO
|
IE |
|
A
|
AXIS Capital Holdings Ltd
F:AXV
|
BM |
|
Z
|
ZIM Integrated Shipping Services Ltd
F:2SV
|
IL |
|
M
|
Metso Oyj
SWB:M6Q
|
FI |
|
L
|
LPL Financial Holdings Inc
F:7LI
|
US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
Siemens AG
XETRA:SIE
|
DE |
|
Dave Inc
NASDAQ:DAVE
|
US |
Bankruptcy Probability
argenx SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
argenx SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BeOne Medicines AG
SSE:688235
|
226.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
argenx SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, argenx SE has total debt of 36m USD. This includes both short-term (0 USD) and long-term (36m USD) debt.
You can find a full breakdown on its Balance Sheet.
